Detalhe da pesquisa
1.
Doravirine exposure and HIV-1 suppression after switching from an efavirenz-based regimen to doravirine/lamivudine/tenofovir disoproxil fumarate.
Antimicrob Agents Chemother
; 63(12)2019 09 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31548188
2.
Elbasvir/grazoprevir does not worsen renal function in patients with hepatitis C virus infection and pre-existing renal disease.
Hepatol Res
; 47(12): 1340-1345, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28334495
3.
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.
Lancet
; 386(10003): 1537-45, 2015 Oct 17.
Artigo
Inglês
| MEDLINE | ID: mdl-26456905
4.
Heavy antiretroviral exposure and exhausted/limited antiretroviral options: predictors and clinical outcomes.
AIDS
; 38(4): 497-508, 2024 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38079588
5.
HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.
J Virol
; 86(2): 1119-28, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22090117
6.
Characterization of emergent HIV resistance in treatment-naive subjects enrolled in a vicriviroc phase 2 trial.
J Infect Dis
; 201(10): 1470-80, 2010 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20373959
7.
Brief Report: Switching to DOR/3TC/TDF Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT Trial.
J Acquir Immune Defic Syndr
; 87(2): 801-805, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33633036
8.
Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211.
J Infect Dis
; 200(11): 1724-8, 2009 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19874179
9.
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.
Clin Infect Dis
; 48(5): 642-9, 2009 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19191652
10.
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions.
J Clin Microbiol
; 47(8): 2604-6, 2009 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-19494074
11.
In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject.
J Virol
; 82(16): 8210-4, 2008 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-18495779
12.
Evaluation of Neural Tube Defects (NTDs) After Exposure to Raltegravir During Pregnancy.
J Acquir Immune Defic Syndr
; 81(3): 247-250, 2019 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30908331
13.
Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial.
J Acquir Immune Defic Syndr
; 81(4): 463-472, 2019 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30985556
14.
Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial.
J Acquir Immune Defic Syndr
; 78(5): 589-598, 2018 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29771789
15.
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Clin Infect Dis
; 44(4): 591-5, 2007 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17243065
16.
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection.
World J Hepatol
; 9(4): 217-223, 2017 Feb 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28217259
17.
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.
Lancet Gastroenterol Hepatol
; 2(8): 585-594, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28576451
18.
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Clin Infect Dis
; 42(8): 1179-86, 2006 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16575739
19.
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.
Lancet Infect Dis
; 13(7): 597-605, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23768747
20.
Detection of HIV-1 CXCR4 tropism and resistance in treatment experienced subjects receiving CCR5 antagonist-Vicriviroc.
J Clin Virol
; 55(2): 134-9, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22824230